NP47923c Eculizumab

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Supply)
Duration
23.5 month (est.)
Value
£11M
Sector
HEALTH
Published
07 Feb 2024
Delivery
To 27 Jan 2026 (est.)
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 3 suppliers

2 buyers

3 suppliers

Description

Supply of eculizumab to NHS Scotland.

Total Quantity or Scope

Supply of eculizumab vials to NHS Scotland. The Authority has awarded this framework as an unranked multi-supplier framework per product line to three (3) Framework Participants.

Award Detail

1 Amgen (Cambridge)
  • Num offers: 3
  • Value: £10,508,400 [share]
  • Awarded to group of suppliers.
2 Alexion Rare Disease Part of Astra Zeneca (Uxbridge)
  • Num offers: 3
  • Value: £10,508,400 [share]
  • Awarded to group of suppliers.
3 Samsung Bioepis (Brentford)
  • Num offers: 3
  • Value: £10,508,400 [share]
  • Awarded to group of suppliers.
  • Contractor is an SME.

Award Criteria

API Sources 5.0
PRICE 95.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

The estimated values referred to in Section II.1.5 and covers the initial duration of the framework and the stated extension period of the framework. (SC Ref:756868)

Reference

Domains